Literature DB >> 29748406

Draft Genome Sequencing of an Acinetobacter ursingii Isolate from Healthy Human Skin, Carrying Multidrug Resistance Genes.

Lenka Palkova1, Gabriel Minarik2, Katarina Soltys3.   

Abstract

In this paper, we report the data from whole-genome shotgun sequencing of an Acinetobacter ursingii isolate from healthy human skin of the forearm. The bacterial genome includes 3,473 genes and carries beta-lactamase resistance genes as well as resistance genes for several heavy metals.
Copyright © 2018 Palkova et al.

Entities:  

Year:  2018        PMID: 29748406      PMCID: PMC5946048          DOI: 10.1128/genomeA.00394-18

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Although Acinetobacter spp. are naturally present on human skin, this bacterium can act as a potential pathogen and cause severe bacteremia (1–3). It is capable of long-term survival and transfer in intensive care units. These characteristics, in combination with increasing antibiotic resistance, make this bacterium considerably frightening (4, 5). Acinetobacter ursingii is a relatively new species (6), and its identification is still problematic (7). This may contribute to fact that among other Acinetobacter spp., A. ursingii is rarely identified (8). Here, we report results of whole-genome shotgun sequencing of an A. ursingii isolate, strain blaTEM-116. The sample was obtained from the collection of bacterial strains of the Department of Molecular Biology, Comenius University, Bratislava, Slovakia. It was defined to be an isolate from healthy human skin obtained from an individual in a nonclinical environment. A single bacterial colony was cultivated on MacConkey agar (Sigma-Aldrich, Munich, Germany). Genomic DNA was isolated using a DNeasy blood and tissue kit (Qiagen, Hilden, Germany). A transposon-based sequencing library was prepared using a Nextera XT kit (Illumina, San Diego, CA). The DNA profile of the library was verified by using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) and quantified with a Qubit 2.0 fluorometer (Thermo Fisher Scientific, Waltham, USA). The library was sequenced using paired-end sequencing on an Illumina MiSeq platform (Illumina, San Diego, CA, USA). The quality of reads was checked with the FastQC tool. De novo assembly was performed with CLC Genomics Workbench (length fraction, 0.5; similarity fraction, 0.8). Annotation of the sequence was performed with the NCBI Prokaryotic Genome Annotation Pipeline using the best-placed reference set with GeneMarkS+ v. 4.4 (https://www.ncbi.nlm.nih.gov/genome/annotation_prok/). A total of 3,079,326 paired reads and 636,809 single sequencing reads were obtained and assembled into 194 contigs longer than 200 bp, with 40% GC content. The A. ursingii isolate was identified according to the whole-genome sequencing (WGS) database of GenBank. The total DNA sequence is 3,578,188 bp long and provides 3,473 genes. These include 3,236 coding genes and 78 RNA genes (12 rRNAs, 62 tRNAs, and 4 noncoding RNAs [ncRNAs]). There was no plasmid detected using the online tool PlasmidFinder (https://cge.cbs.dtu.dk/services/PlasmidFinder/). A remarkable finding was the presence of the following resistance genes for heavy metals: copper (multicopper oxidase, copB, copC, copD, cutE, corC, cusR, and copper-translocating P-type ATPase), tellurium (terZ), arsenic (arsB, arsH, arsR, arsC, and acr3), cobalt-zinc-cadmium complex (cusA, cusB, czcA, czsB, czcD, czrR, and TR), and chromium compounds (chrA). In the bacterium genome, beta-lactamase resistance genes class A (TEM-116) and class C (BL and BLc) were found, as well as the following genes involved in drug resistance machinery: multidrug resistance efflux/transporter genes (Bcr/CflA family, RND, OML, cmeB, cmeC, MATE family of MDR efflux pumps, macA, macB, tolC, and arcB), toxic anion resistance protein, glyoxalase/bleomycin resistance/extradiol dioxygenase family protein, organic hydroperoxide resistance protein, methyl viologen resistance protein smvA, hdeD family acid-resistance protein, chemical-damaging agent resistance protein C, resistance-to-fluoroquinols genes (gyrA, and gyrB), and bile hydrolysis genes (bsh, and AKGTO). Furthermore, we found a cluster of genes associated with colicin V and bacteriocin production (dedA, dedE, R1, R3, R4, R5, and purF) and other virulence-associated genes and genes associated with invasion and intercellular resistance, including active virulence operons involved in protein synthesis (rv0682, rv0683, rv0684, rv0685, rv1641, rv1642, and rv1643), DNA transcription (rv0667 and rv0668), quinolinate biosynthesis (rv1594, rv1595, and rv1596), and internalin-like proteins.

Accession number(s).

This whole-genome shotgun project has been deposited in GenBank under the accession no. PTPV00000000. The version described in this paper is version PTPV01000000 and consists of sequences PTPV01000001 to PTPV01000194. The sequence of the 16S rRNA gene has been deposited in GenBank under the accession no. MH113156.
  8 in total

1.  Impact of Acinetobacter spp. in intensive care units in Great Britain and Ireland.

Authors:  H Humphreys; K J Towner
Journal:  J Hosp Infect       Date:  1997-12       Impact factor: 3.926

2.  Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens.

Authors:  Laurent Dortet; Patrick Legrand; Claude-James Soussy; Vincent Cattoir
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

3.  Bacteremia caused by Acinetobacter ursingii.

Authors:  Julien Loubinoux; Liliana Mihaila-Amrouche; Anne Le Fleche; Etienne Pigne; Gerard Huchon; Patrick A D Grimont; Anne Bouvet
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

4.  Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens.

Authors:  A Nemec; T De Baere; I Tjernberg; M Vaneechoutte; T J van der Reijden; L Dijkshoorn
Journal:  Int J Syst Evol Microbiol       Date:  2001-09       Impact factor: 2.747

5.  Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species.

Authors:  Jane F Turton; Jayesh Shah; Chika Ozongwu; Rachel Pike
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

6.  Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods.

Authors:  H Seifert; L Dijkshoorn; P Gerner-Smidt; N Pelzer; I Tjernberg; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  First case of post-endoscopic retrograde cholangiopancreatography bacteraemia caused by Acinetobacter ursingii in a patient with choledocholithiasis and cholangitis.

Authors:  Victoria Ortiz de la Tabla Ducasse; Coral Martín González; Juan A Sáez-Nieto; Félix Gutiérrez
Journal:  J Med Microbiol       Date:  2008-09       Impact factor: 2.472

8.  Severe Community-Acquired Bloodstream Infection with Acinetobacter ursingii in Person who Injects Drugs.

Authors:  Helmut J F Salzer; Thierry Rolling; Stefan Schmiedel; Eva-Maria Klupp; Christoph Lange; Harald Seifert
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

  8 in total
  1 in total

1.  Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains.

Authors:  Nadeem Ullah; Ling Hao; Jo-Lewis Banga Ndzouboukou; Shiyun Chen; Yaqi Wu; Longmeng Li; Eman Borham Mohamed; Yangbo Hu; Xionglin Fan
Journal:  Pathogens       Date:  2021-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.